Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2024HaemophiliaOpen Access

Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease

View Full Paper
Ask AI
Bookmark
Share

Authors

GKGeoffrey Zinu Lukas KuppensUtrecht UniversityKFKathelijn FischerUniversity Medical Center UtrechtKGKarin P. M. van GalenUtrecht University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kuppens et al. (2024) studied this question.

synapsesocial.com/papers/68e6046bb6db643587597ae9https://doi.org/10.1111/hae.15079
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease2021 · 401 citations
  2. 2von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 12008 · 970 citations
  3. 3Treatment of von Willebrand's Disease2004 · 486 citations
  4. 4Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease: Identifying the need for personalized treatment2018 · 41 citations
  5. 5High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism2000 · 768 citations